Business & Entrepreneurship

Robi Mitra at WashU Medicine has received the Chancellor’s Award for Innovation and Entrepreneurship. In addition, in 2024 WashU jumped 11 places to No. 26 on the National Academy of Inventors list of the top 100 U.S. universities granted U.S. utility patents.

As the Oklahoma Legislature clears the way for autonomous practice by nurse practitioners, it’s time for a broader conversation regarding the scope and duration of training and certification needed to independently provide care to patients of all types, says Patrick Aguilar, MD, a business of health expert at WashU Olin Business School.

WashU School of Public Health Dean Sandro Galea, MD, DrPH, and Olin Business School Dean Michael Mazzeo led a two-day dialogue bringing together dozens of experts in academic public health and business from around the world. 

From Eagle Scout to Ervin Scholar, M.J. Brown leads with commitment to service and values. Now the soon-to-be Olin Business School graduate prepares to follow his dreams across the country where he’ll work as an associate product marketing manager at Google in San Francisco.

Three St. Louis startups won the first-ever WashU Venture Network Follow-on Investments April 17 during a special Skandalaris Center event.

John Horn, a professor of practice in economics at Olin Business School at Washington University in St. Louis, explains how tariff uncertainty and confusion is contributing to market volatility — and how this might impact long-term economic trends.

In collaboration with WashU partners, Olin Dean Mike Mazzeo seeks to enable the commercialization of medical discoveries.

WashU’s Digital Intelligence & Innovation Accelerator and WashU Libraries recently awarded funding to faculty developing open educational resources for students.

WashU rises in the National Academy of Inventors’ annual global ranking of patent awards.

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.